Can I read QTc-Prolongation Risk Score Development on EtoBox?

QTc-Prolongation Risk Score Development by Jhampier Raigosa is a document available to read on EtoBox.

What is QTc-Prolongation Risk Score Development about?

The RISQ-PATH study developed a risk score to identify hospitalized patients at high or low risk for QTc-prolongation when starting QTc-prolonging medications. The study found that 14.6% of patients developed a prolonged QTc-interval, and the preliminary RISQ-PATH score demonstrated a negative predictive value of 98.0% for ruling out low-risk patients. This score is promising for clinical practice as it aids in monitoring and managing the risk of QTc-prolongation in patients receiving such medications.

Author

Jhampier Raigosa

Language

EN